MedPath

Molecular Taxonomy of Surgically-harvested Ocular Tissues Defined by Single-cell Transcriptomics

Not Applicable
Conditions
Glaucoma
Diabetic Retinopathy
Proliferative Vitreoretinopathy
Pterygium
Interventions
Procedure: ocular surgery
Registration Number
NCT04682054
Lead Sponsor
The First Affiliated Hospital with Nanjing Medical University
Brief Summary

The surgically-harvested eye tissue (ie. vitreous-retinal proliferative membrane, outflow pathway, retinas, and pterygium) is a complex tissue responsible for maintaining intraocular homeostasis or mediating ocular pathogenesis. Dysfunction of one or more resident cell types within the tissues results in different ocular disorder, leading to vision loss, or even blindness. In this study, we aim to use single-cell RNA sequencing to generate a comprehensive cell atlas of surgically-harvested eye tissues.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  1. Patients with ocular diseases and require surgery intervention.
  2. The surgery intervention remove pathological tissue during surgery.
  3. Patients consent to the treatment and single-cell sequencing.
Exclusion Criteria
  1. Surgically removed eye tissue cannot meet with the quality control of single-cell sequencing (mainly the tissue weight and cell counts);

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
surgically-removed eye tissueocular surgery-
Primary Outcome Measures
NameTimeMethod
counts of each cell type1 month

single-cell sequencing identify what cells and the counts within the eye tissue

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

First Affiliated Hospital of Nanjing Medical University

🇨🇳

Nanjing, Jiangsu, China

© Copyright 2025. All Rights Reserved by MedPath